1. Home
  2. VKTX vs DTM Comparison

VKTX vs DTM Comparison

Compare VKTX & DTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • DTM
  • Stock Information
  • Founded
  • VKTX 2012
  • DTM 2021
  • Country
  • VKTX United States
  • DTM United States
  • Employees
  • VKTX N/A
  • DTM N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • DTM Oil & Gas Production
  • Sector
  • VKTX Health Care
  • DTM Utilities
  • Exchange
  • VKTX Nasdaq
  • DTM Nasdaq
  • Market Cap
  • VKTX 4.7B
  • DTM 10.1B
  • IPO Year
  • VKTX 2015
  • DTM N/A
  • Fundamental
  • Price
  • VKTX $41.49
  • DTM $101.50
  • Analyst Decision
  • VKTX Strong Buy
  • DTM Hold
  • Analyst Count
  • VKTX 12
  • DTM 10
  • Target Price
  • VKTX $106.75
  • DTM $89.56
  • AVG Volume (30 Days)
  • VKTX 3.6M
  • DTM 988.2K
  • Earning Date
  • VKTX 02-05-2025
  • DTM 02-14-2025
  • Dividend Yield
  • VKTX N/A
  • DTM 2.96%
  • EPS Growth
  • VKTX N/A
  • DTM 15.08
  • EPS
  • VKTX N/A
  • DTM 4.11
  • Revenue
  • VKTX N/A
  • DTM $976,000,000.00
  • Revenue This Year
  • VKTX N/A
  • DTM $8.02
  • Revenue Next Year
  • VKTX N/A
  • DTM $18.98
  • P/E Ratio
  • VKTX N/A
  • DTM $24.20
  • Revenue Growth
  • VKTX N/A
  • DTM 5.97
  • 52 Week Low
  • VKTX $17.23
  • DTM $51.17
  • 52 Week High
  • VKTX $99.41
  • DTM $109.85
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 35.23
  • DTM 49.28
  • Support Level
  • VKTX $39.09
  • DTM $98.62
  • Resistance Level
  • VKTX $43.48
  • DTM $100.78
  • Average True Range (ATR)
  • VKTX 2.15
  • DTM 2.19
  • MACD
  • VKTX 0.10
  • DTM -0.30
  • Stochastic Oscillator
  • VKTX 28.04
  • DTM 57.84

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About DTM DT Midstream Inc.

DT Midstream Inc is an owner, operator, and developer of natural gas midstream interstate and intrastate pipelines; storage and gathering systems; and compression, treatment, and surface facilities. It provides multiple, integrated natural gas services to customers through interstate pipelines, intrastate pipelines, storage systems, lateral pipelines and related treatment plants and compression and surface facilities, and gathering systems and related treatment plants and compression and surface facilities. The segments of the group are Pipeline and Gathering. It generates revenue from pipeline, storage, and gathering systems, substantially all of which are located in the Midwestern U.S., Eastern Canada, Northeastern U.S., and Gulf Coast regions.

Share on Social Networks: